A massive gap has opened between the survival changes of patients with some common cancers and those with the rarest forms of the disease, according to figures published yesterday.
Just 5% of patients with cancer of the pancreas live for five years after diagnosis, according to the figures from the UK’s Office for National Statistics.
The figures show that five-year survival is less than 21% for cancers of the brain, lung, oesophagus and stomach.
In contrast more than 80% of patients survive at least five years after being diagnosed with cancers of the breast and prostate together with those with melanoma and Hodgkin lymphoma.
Patients with colorectal cancer have a 57% chance of living for five years.
The charity Macmillan Cancer Support said the figures highlighted "inequalities in cancer survival."
Mike Hobday, of the charity, said: “Every cancer patient should expect the very best chances of survival – no matter what type of the disease they have. It is vital that the variation between cancer types continues to be monitored and reported at a national level.
"We also need further research to allow us to better understand the reasons for these inequalities in cancer survival so that we can take action to address them.”

Leave a Reply